Single versus bilateral internal thoracic artery grafts with concomitant saphenous vein grafts for multivessel coronary artery bypass grafting: effects on mortality and event-free survival  by Stevens, L.M. et al.
Single versus bilateral internal thoracic artery grafts with
concomitant saphenous vein grafts for multivessel coronary
artery bypass grafting: Effects on mortality and event-free
survival
L. M. Stevens, MDb
M. Carrier, MDa,b
L. P. Perrault, MD, PhDa,b
Y. He´bert, MDb
R. Cartier, MDa,b
D. Bouchard, MDb
A. Fortier, MSca
I. El-Hamamsy, MDb
M. Pellerin, MDa,b
Dr Stevens
Background: The issue of superiority of single internal thoracic artery grafting
versus bilateral internal thoracic artery grafting remains unresolved. The aim of this
study was to compare the long-term outcome of single and bilateral internal thoracic
artery grafting with concomitant saphenous vein grafting for multivessel coronary
artery bypass grafting.
Methods: Between March 1985 and April 1995, 6650 patients underwent pri-
mary isolated coronary artery bypass grafting with internal thoracic artery
grafts, including 4382 patients with multivessel bypass grafting requiring at
least 3 grafts. Outcomes of patients undergoing single internal thoracic artery
plus saphenous vein grafting (n  2547) and bilateral internal thoracic artery
plus saphenous vein grafting (n  1835) were obtained at a mean follow-up of
11  3 years.
Results: Patients with bilateral internal thoracic artery grafting were younger, were
mostly male, and had less diabetes, hypertension, unstable angina, and recent
myocardial infarction than patients undergoing single internal thoracic artery
grafting. Thirty-day mortality was 2.3% for the group undergoing single internal
thoracic artery grafting versus 1.2% for those undergoing bilateral internal
thoracic artery grafting (P  .007). Survival probability at 10 years was 88% for
the single-graft group compared with 93% for the bilateral-graft group (P 
.001). Multivariate analysis with propensity scoring showed that bilateral inter-
nal thoracic artery grafting decreased the risk of death (hazard ratio, 0.74; 95%
confidence interval, 0.60-0.90), myocardial infarction (hazard ratio, 0.79; 95%
confidence interval, 0.67-0.93), and coronary reoperation (hazard ratio, 0.41;
95% confidence interval, 0.21-0.80) throughout the follow-up period. Other
significant predictors of death were diabetes, prior myocardial infarction, need
for intra-aortic balloon pump, chronic heart failure, and peripheral vascular
disease.
Conclusion: Patients undergoing bilateral internal thoracic plus saphenous vein
grafting appear to have a significantly better long-term clinical outcome than
patients undergoing single internal thoracic artery plus saphenous vein grafting for
multivessel coronary artery bypass grafting.
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Single internal thoracic artery (SITA) graftingto the left anterior descending coronary arteryhas consistently shown benefits over saphe-nous vein grafting (SVG) in terms of long-term patency, survival, and freedom from car-diac events.1-3 However, controversies still
persist concerning the clinical advantages of bilateral inter-
nal thoracic artery (BITA) grafting. Farinas and colleagues,4
from our institution, have compared the late clinical out-
comes of 600 consecutive patients who underwent coronary
artery bypass grafting (CABG) with SVG only (n  200),
SITA grafting (n 200), and BITA grafting (n 200) at 10
years of mean follow-up. Ten-year survival after CABG
was similar in patients with SITA or BITA grafts, although
patients with BITA grafts had a greater number of poor
prognostic factors and a higher recurrence rate of angina
and need for percutaneous coronary interventions (PCIs)
during follow-up. Lytle and coworkers5 reported that pa-
tients who received 2 internal thoracic artery (ITA) grafts
had a decreased risk of death, reoperation, and angioplasty.
Furthermore, 2 recent meta-analyses6,7 of up to 7 published
studies of at least 100 patients and 4 years’ follow-up have
shown a better survival in the BITA group versus that in the
SITA group. Although some authors have suggested im-
proved outcomes with BITA grafting, SITA grafting re-
mains the choice of most surgeons because of the contro-
versy regarding short- and long-term results.
The objective of this study was to compare the long-term
outcome of patients who underwent either SITA plus SVG
or BITA plus SVG for multivessel CABG. We retrospec-
tively studied the late clinical outcomes of 4382 consecutive
patients who underwent isolated CABG at the Montreal
Heart Institute between 1985 and 1995. The primary out-
come of the study was death from any cause. Secondary
outcomes were occurrence of acute myocardial infarction,
need for PCI, need for coronary reoperation, event-free
survival, and the composite end point consisting of death,
myocardial infarction, PCI, and coronary reoperation.
Materials and Methods
Between January 1985 and December 1995, 6650 consecutive
adult patients underwent primary and isolated CABG with ITA
grafting at the Montreal Heart Institute. All patients who under-
went multivessel CABG with at least 3 grafts were included in the
present analysis. Excluded were patients undergoing single and
double CABG, patients who had a concomitant valve procedure or
other cardiac procedures, patients undergoing reoperation, and
patients with grafting using the right gastroepiploic artery (n 
65). Other arterial conduits, such as the radial artery, were not used
during the study period. We therefore analyzed the outcome of
patients undergoing SITA plus SVG (n  2547) and BITA plus
SVG (n  1835) for multivessel CABG.
The indication for myocardial revascularization was based on
standard angiographic and clinical criteria. The left ITA was
harvested as a pedicle and usually grafted on the left anterior
descending artery or a diagonal branch; when used, the right ITA
was mostly harvested pedicled, aiming at the circumflex or the
right coronary territory or used as a free graft.4 Patients underwent
SITA or BITA grafting depending on the preference of the attend-
ing surgeon. Selection criteria favoring SITA grafting over BITA
grafting were insulin-dependent diabetes, chronic obstructive pul-
monary disease, older age, and serious comorbidities affecting
long-term survival (diffuse disease, severe peripheral vascular
disease, and dialysis-dependent renal insufficiency). Demographic
variables (sex and age) and risk factors for coronary artery disease
and major comorbidities were obtained by means of retrospective
review of the institutional discharge summary.
Patient survival during follow-up and the occurrence of acute
myocardial infarction, coronary reoperation, and PCI were re-
corded. Follow-up data were obtained by matching the patients’
health insurance numbers in the institutional database with the
corresponding files in a governmental centralized health care da-
tabase (Re´gie de l’assurance-maladie du Que´bec) in which all
deaths and episodes of health care use (in and out of the hospital)
are recorded. Permission to use the denominated database was
obtained from the Information Access Board of the Quebec gov-
ernment. Follow-up was complete except for 76 patients (62 in the
SITA group and 14 in the BITA group) for whom the health
insurance numbers were unavailable; these were mostly foreign
patients. Thus complete data were available for 4306 (98%) of the
4382 patients. The mean duration of follow-up was higher in the
SITA group (12  3 years) than in the BITA group (8  2 years,
P  .001) for an overall mean follow-up of 11  3 years.
Data are expressed as means  SD or medians (ranges) for
continuous variables and frequency for categoric variables. Uni-
variate analysis was performed with the Student t test and the
Wilcoxon test depending on the distribution of the continuous
variable and the 2 test for categoric variables. Stepwise logistic
regression models were used to determine the influence of demo-
graphic and operative covariates on early survival. Survival anal-
ysis was performed with the Kaplan-Meier method, and the log-
rank test was used to compare curves. Cox proportional hazard
regression models were used to determine the influence of demo-
graphic and operative covariates on late survival, freedom from
myocardial infarction, PCI and coronary reoperation, and event-
free survival. Hazard ratios (HRs), 95% confidence intervals (CIs)
and levels of statistical significance (P value) were calculated. The
statistical analyses were performed with SAS release 8.2 (SAS
Institute, Cary, NC).
The influence of BITA grafting on outcome was analyzed by
using a stepwise multivariate approach with use of the propensity
score to better account for selection bias in both groups. First, we
calculated a propensity score for each patient. Variables included
in the propensity score are listed in Appendix 1. Demographic data
were then compared for the SITA and BITA groups in each
quintile. There were few intergroup differences in each quintile, as
shown in Appendix 2: patients with SITA grafting were younger in
quintile 4 and older in quintile 5, presented more hypertension in
quintile 1, and presented more recent myocardial infarction in
quintile 5 than patients with BITA grafting. As pointed out by
Blackstone,8 it is common that 2% to 3% of variables included in
the propensity score remain slightly different. As shown, the
number of patients from both groups in each quintile was sufficient
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to keep all patients in the final model. The propensity score was
used as a categoric variable, as recommended by D’Agostino.9
Second, multivariate analysis was performed by forcing sequen-
tially the group variable (SITA vs BITA) and the propensity score
in the model before including the covariables identified in the
univariate analysis. For an illustrative purpose, we also obtained
survival curves corrected for the propensity score and the signif-
icant covariables.
Results
Patient Characteristics
Patients who underwent CABG with BITA grafting were
younger and less likely to have diabetes, hypertension, unsta-
ble angina, recent myocardial infarction, peripheral vascular
disease, and chronic obstructive disease before CABG than
patients undergoing SITA grafting (Table 1). Fewer patients in
the BITA group were operated on after a failed PCI or required
perioperative insertion of an intra-aortic balloon pump (IABP).
Dyslipidemia was more prevalent in the BITA group. The
prevalence of chronic heart failure and obesity was similar in
both groups. Patients undergoing BITA grafting had a slightly
higher number of coronary artery grafts performed than those
undergoing SITA grafting (Table 2).
Early Results
Both groups experienced similar operative mortalities and
rates of reoperation for bleeding and sternal wound infec-
tion. The 30-day and in-hospital mortalities were signifi-
cantly higher for the SITA grafting group (Table 2). How-
ever, SITA grafting was not identified as a predictor of
30-day mortality compared with BITA grafting in the step-
wise multiple regression analysis (Table 3). Significant pre-
dictors of 30-day mortality were female sex, preoperative
chronic heart failure, peripheral vascular disease, chronic
obstructive pulmonary disease, need for perioperative
IABP, and reoperation for bleeding. Hospital stay was 1 day
longer in the SITA group.
Late Results and Survival
Survival of patients 5, 10, and 15 years after the operation
averaged 97%, 93%, and 89% in the BITA group compared
with 95%, 88%, and 79% in the SITA group, respectively.
Globally, the Kaplan-Meier curves of the 2 groups were
statistically different (P  .001, Figure 1). Patients who
underwent BITA grafting had significantly better freedom
from myocardial infarction (P  .001; 10-year freedom
from myocardial infarction: 85% vs 82% for the BITA and
SITA groups, respectively; Figure 2) and from coronary
reoperation (P  .01; 10-year freedom from coronary re-
operation: 99% vs 98% for the BITA and SITA groups,
respectively) and better event-free survival (P  .001; Fig-
ure 3) compared with patients in the SITA group. The
freedom from PCI was similar in both groups.
Multivariate Analysis of Differences in Outcomes
Significant factors influencing each outcome (death, myo-
cardial infarction, PCI, and coronary reoperation) and step-
wise multivariate analysis of the influence of BITA grafting
with propensity score, multivariate analysis, or both are
presented in Table 4. The HRs favor patients undergoing
BITA grafting in decreasing long-term death, in preventing
myocardial infarction and coronary reoperation, and in in-
creasing overall event-free survival. Other significant pre-
dictors of long-term death were older age, presence of
diabetes, preoperative chronic heart failure, peripheral vas-
cular disease, chronic obstructive pulmonary disease, and
prior myocardial infarction.
Multivariate analysis of other risk factors for myocardial
infarction identified younger age, diabetes, peripheral vas-
cular disease, and prior myocardial infarction as significant
predictors of late myocardial infarction. Significant predic-
tors of coronary reoperation were younger age, preoperative
failed PCI, and peripheral vascular disease. Significant pre-
dictors of the use of PCI after initial CABG surgery were
younger age and female sex. After regrouping events of
death, myocardial infarction, PCI, and coronary reoperation,
significant predictors of long-term events were obtained:
younger age, diabetes, peripheral vascular disease, chronic
obstructive pulmonary disease, prior myocardial infarction,
and perioperative need for IABP.
TABLE 1. Patient characteristics
SITA
(n  2498)
BITA
(n  1808) P value
Age, y 63 9 57 9 .0001
Sex (female), n (%) 627 (25%) 208 (12%) .0001
Diabetes, n (%) 419 (18%) 214 (12%) .0001
Hypertension, n (%) 361 (14%) 201 (11%) .0013
Unstable angina, n (%) 612 (25%) 380 (21%) .0074
Prior myocardial infarction
(MI)
Recent MI, n (%) 228 (9%) 129 (7%) .0193
Old MI, n (%) 594 (24%) 391 (22%) .0969
Preoperative percutaneous
coronary intervention, n (%)
39 (1.6%) 15 (0.8%) .0332
Perioperative intraaortic
balloon pump need, n (%)
198 (8%) 99 (5%) .0017
Preoperative, n (%) 52 (2%) 18 (1%)
Intraoperative, n (%) 135 (5%) 76 (4%)
Postoperative, n (%) 14 (1%) 7 (0%)
Chronic heart failure, n (%) 37 (1.5%) 19 (1.1%) .2187
Peripheral vascular disease,
n (%)
195 (8%) 99 (5%) .0028
Obesity, n (%) 289 (12%) 180 (10%) .0935
Dyslipidemia, n (%) 272 (11%) 321 (18%) .0001
Chronic obstructive pulmonary
disease, n (%)
151 (6%) 69 (4%) .0010
SITA, Single internal thoracic artery grafting; BITA, bilateral internal tho-
racic artery grafting; MI, myocardial infarction.
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The difference in patient survival between the 2 groups
persisted after correction for the propensity score and sig-
nificant covariables, with adjusted survivals averaging 97%,
93%, and 88% in the BITA group compared with 96%,
91%, and 84% in the SITA group 5, 10 and 15 years after
the operation, respectively (Figure 4).
Discussion
The major findings of this retrospective study are that BITA
grafting is better than SITA grafting for patients with mul-
tivessel CABG and concomitant use of SVG. Patients who
underwent BITA plus SVG for multivessel coronary artery
disease showed better overall survival and event-free sur-
vival and higher rates of freedom from myocardial infarc-
tion and coronary reoperation compared with patients who
underwent SITA plus SVG.
Controversy still persists about the clinical benefit of
BITA grafting over the already good results of SITA graft-
ing. Unfortunately, there is no conclusive prospective ran-
domized clinical trial published or ongoing comparing SITA
and BITA grafting. As pointed out by Taggart and associates6
and others,4,5 a prospective randomized trial would be arduous,
with demonstration of a 5% reduction in mortality at 10 years
with 90% power and a 1% significance level requiring ran-
domization of about 4200 patients and follow-up of at least 10
years. BITA grafting has not met wide acceptance among
surgeons because of the perception of an increased periopera-
tive risk reported in earlier trials and because BITA grafting is
technically more demanding.6,10
Usually, surgeons tend to offer BITA grafting to patients
with low surgical risk and the greatest chance of survival and
long-term benefit from CABG.5 With the benefit of coronary
artery bypass surgery over percutaneous techniques demon-
strated in sicker patient subgroups (ie, left-main disease, 3-ves-
sel disease, diabetes, and heart failure)11 and the recent ad-
vancement in coronary artery stenting, the population referred
for surgical intervention has changed markedly. Faced with
higher-risk patients, surgeons should question whether the
choice of surgical technique can improve the long-term bene-
fits of patients undergoing CABG. Challenged by this ques-
tion, we retrospectively reviewed the results of patients under-
going multivessel CABG who underwent SITA plus SVG
compared with those of patients who underwent BITA plus
SVG.
Although Lytle and colleagues5 have shown that “2
internal thoracic artery grafts are better than one,” complex
methods of statistical analysis were used to address the
variation in confounding factors between the 2 groups, and
patients who underwent SITA grafting were not consecu-
tive. Also, the authors included all patients undergoing
primary isolated revascularization with both ITAs, includ-
ing patients with complete arterial grafting (both ITAs and
no SVG). To address some of these biases, we included all
patients undergoing primary isolated revascularization with
TABLE 3. Predictors of 30-day mortality
Variable
Odds ratio estimate
(95% confidence
interval) P value
BITA 0.65 (0.38-1.11) .1121
Sex, (female vs male) 1.86 (1.12-3.07) .0158
CHF 3.53 (1.32-9.47) .0121
PVD 2.01 (1.08-3.76) .0282
COPD 2.99 (1.42-6.29) .0039
Need for IABP 13.8 (8.45-22.54) .0001
Reoperation for bleeding 3.08 (1.61-5.89) .0007
BITA, Bilateral internal thoracic artery grafting; CHF, chronic heart failure;
PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary
disease; IABP, intra-aortic balloon pump.
TABLE 2. Operative data and postoperative course
SITA
(n  2498)
BITA
(n  1808) P value
Operative data
No. of grafts per patient, mean 3.2 0.5 3.4 0.6 .0001
3 grafts, n (%) 1952 (78%) 1187 (66%)
4 grafts, n (%) 497 (20%) 560 (31%)
5 grafts n (%) 49 (2%) 61 (3%)
No. of ITA grafts, n 2545 3784
No. of SVG, n 2498 1808
Postoperative complications
Reoperation for bleeding, n (%) 124 (5%) 76 (4%) .2419
Sternal wound infection, n (%) 34 (1.4%) 22 (1.2%) .6800
Mortality
Operative, n (%) 7 (0.3%) 3 (0.2%) .4419
30-day, n (%) 57 (2.3%) 21 (1.2%) .0065
Hospital, n (%) 64 (2.6%) 23 (1.3%) .0030
LOS in hospital (d), median (range) 8 (0-129) 8 (0-118) .0001
SITA, Single internal thoracic artery grafting; BITA, bilateral internal thoracic artery grafting; SVG, sapherous vain graft; LOS, length of stay.
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SITA plus SVG or BITA plus SVG and excluded single and
double CABG.
Predictors of 30-Day Mortality
In the most recent series, early mortality is similar for patients
who underwent SITA or BITA grafting.2,5,12-15 In the present
series 30-day and hospital mortalities was significantly lower
for the BITA group. Nevertheless, SITA grafting versus BITA
grafting was not identified as a significant predictor of 30-day
mortality in multivariate analyses.
Postoperative Complications
Several studies have reported BITA grafting as an indepen-
dent risk factor for sternal wound infection,5,15-18 along with
obesity,15,16,18 diabetes, older age,12,18 reoperation, and pro-
longed use of inotropic agents18 or prolonged mechanical
ventilation. We have previously shown that ITA dissection
as a pedicle causes a significant, although partial and tem-
porary, sternal ischemia that is more severe after BITA than
SITA mobilization.19 Skeletonization of the ITA seems to
have decreased the risk of sternal wound complications, but
obese diabetic patients still make up a group that is at an
increased risk and thus a relative contraindication to the use
of BITA grafting.20 In the present report both groups had
similar rates of sternal wound infection and reoperation for
bleeding, possibly because of better selection of patients for
BITA grafting. Hospital stay was significantly longer in the
SITA group than in the BITA group, reflecting the differ-
ence in patient populations and the increased early mortality
in the SITA group.
Survival
Earlier series reported no survival benefit with BITA graft-
ing.3,21-23 However, in a large study with 2001 patients
Figure 1. Kaplan-Meier survival of patients undergoing primary
elective coronary artery bypass for multivessel CABG with SITA
versus BITA.
Figure 2. Freedom from myocardial infarction for patients under-
going primary elective coronary bypass graft for multivessel
CABG with SITA versus BITA.
Figure 3. Event-free survival for patients undergoing primary
elective coronary bypass graft for multivessel CABG with SITA
versus BITA.
Figure 4. Kaplan-Meier survival of patients undergoing primary
elective coronary artery bypass for multivessel CABG with SITA
versus BITA, with correction with propensity score and con-
founding variables for illustrative purposes. No CIs or log-rank
test results were obtained.
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undergoing BITA grafting and 8123 patients undergoing
SITA grafting and longer follow-up, Lytle and colleagues5
reported a significantly better overall survival after BITA
grafting (94%, 84%, and 67%) than after SITA grafting
(91%, 79%, and 64%) at 5, 10, and 15 years postoperatively,
respectively. Also, 2 recent meta-analyses have shown a
significant reduction in mortality after omission of method-
ologically weak investigations (HR, 0.76; 95% CI, 0.67-
0.866 and HR, 0.79; 95% CI, 0.66-0.917). We report a
survival benefit for BITA grafting (97%, 93%, and 89%)
over SITA grafting (95%, 88%, and 79%) at 5, 10, and 15
years postoperatively, respectively. The benefit persisted after
adjustment for propensity score and multivariate analysis and
is consistent with the results of recent published series.
Freedom From Myocardial Infarction, PCI, and
Coronary Reoperation
The benefits of BITA grafting on the freedom from myo-
cardial infarction have been reported by some au-
thors,13,14,24 whereas others could not show a significant
difference.3,22 In our experience BITA grafting significantly
improved the freedom from myocardial infarction at long-
term follow-up. The benefit is more recognizable after 8
years, which could be related to late occlusion of SVG and
the better patency of ITA grafts. This could be explained
also by native disease progression in the higher-risk patients
undergoing SITA grafting; nonetheless, the overall benefit
of BITA grafting over SITA grafting remained after correc-
tion with propensity score. Younger age was identified as a
significant risk factor for myocardial infarction, as well as
need for PCI or coronary reoperation. Blackstone and
Lytle25 and Lytle and colleagues5 recently reported that
young and old patients have quite similar event-free sur-
vival estimates, which is more influenced by coronary re-
intervention in the young and by death in the elderly. In
others words, the expected improvement in survival in
younger patients with BITA grafting is small because young
patients undergoing both BITA and SITA grafting have
favorable survivals compared with the larger benefit of
decreased rate of coronary reintervention.5
A common indication for reintervention, either coronary
reoperation or PCI, is the progression of disease in the
native circulation or failure of saphenous vein or arterial
grafts. After 5 to 15 years’ follow-up, some authors did not
find significant differences in freedom from coronary reop-
eration or PCI,13,14,22 whereas others reported a signifi-
cantly lower occurrence of PCI,23 coronary reoperation, or
both.5 In this report BITA grafting was associated with
improved freedom from coronary reoperation but not PCI.
During the follow-up period, the number of events reported
for PCI (182) and coronary reoperation (52) were far less
than death (500) and myocardial infarction (714), which
limits the conclusions about these 2 outcomes.
Limitations
This study reported the retrospective experience of a single
tertiary center with SITA plus SVG versus BITA plus SVG.
Statistical methods, such as propensity score and multivar-
iate analysis, were used to improve the comparability of the
groups and reduce the influence of selection bias. However,
a retrospective study does not have the strength of a pro-
spective randomized trial, and other patient-related or op-
eration-related factors could influence the results of the
analysis. The population characteristics depended on the
information reported by the attending surgeon on the dis-
TABLE 4. Cox regression multivariate analysis for death, myocardial infarction, percutaneous transluminal coronary
angioplasty, coronary reoperation, and any event at long-term follow-up
Death, HR
(95% CI)
P
value
MI, HR
(95% CI)
P
value
PCI, HR
(95% CI)
P
value
REDO, HR
(95% CI)
P
value
Any event HR
(95% CI)
P
value
BITA
Multivariate 0.65 (0.53-0.80) .001 0.72 (0.62-0.85) .001 0.85 (0.62-1.15) .287 0.33 (0.17-0.63) .001 0.73 (0.64-0.83) .001
Propensity score/
multivariate
0.74 (0.60-0.90) .004 0.79 (0.67-0.93) .004 0.92 (0.67-1.26) .606 0.41 (0.21-0.80) .009 0.79 (0.69-0.91) .001
Age 1.02 (1.01-1.03) .001 0.98 (0.97-0.99) .001 0.95 (0.94-0.97) .001 0.94 (0.91-0.97) .001 0.98 (0.98-0.99) .001
Sex (female vs male)     1.57 (1.10-2.24) .010    
Diabetes 1.81 (1.47-2.23) .001 1.46 (1.20-1.77) .001     1.34 (1.14-1.57) .001
Prior MI 1.36 (1.13-1.63) .001 1.40 (1.20-1.63) .001     1.34 (1.18-1.53) .001
Preoperative PCI 0.31 (0.08-1.23) .095     3.28 (1.01-10.6) .048  
IABP         1.82 (1.49-2.22) .001
CHF 2.73 (1.59-4.67) .001       1.49 (0.95-2.36) .086
PVD 2.24 (1.74-2.89) .001 1.45 (1.11-1.89) .006   2.56 (1.00-6.53) .050 1.48 (1.20-1.83) .001
Obesity   0.76 (0.59-0.98) .034      
Dyslipidemia         0.85 (0.70-1.02) .083
COPD 1.54 (1.12-2.11) .008       1.32 (1.03-1.70) .031
HR, Hazard ratio; MI, myocardial infarction; REDO, coronary reoperation; PCI, percutaneous coronary intervention; BITA, bilateral internal thoracic artery
grafting; IABP, intra-aortic balloon pump; CHF, chronic heart failure; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease.
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charge summary, with the possibility of underreporting.
Some significant risk factors for coronary artery disease
were not available, such as smoking, angina functional
class, and left ventricular ejection fraction. This might have
affected propensity scores and multivariate analyses.
Follow-up data were obtained by review of the govern-
ment database. In the Province of Quebec, the Re´gie de
l’assurance-maladie du Que´bec (RAMQ) serves the entire
population. All residents of Quebec, within the meaning of
the Health Insurance Act, are insured under the Quebec
Health Insurance Plan and have access to medical services,
including cardiac surgery. There is no private clinic for
cardiac surgery in Quebec. A report is sent to the RAMQ
each time a patient is seen in consultation, treated, or
hospitalized or dies. This represents a model of a closed
population and allows precise evaluation and follow-up of
the population studied. Death and occurrence of coronary
reoperation or PCI are consistently reported in the database.
Acute myocardial infarction is specifically defined in the
RAMQ diagnosis manual and reliably reported in the data-
base, although we could only corroborate the results with
our registry when patients were rehospitalized at our insti-
tution. Also, silent myocardial infarctions in patients with
left bundle-branch block could have been missed.
Conclusion
We demonstrated in this large retrospective study that pa-
tients undergoing BITA plus SVG for multivessel CABG
have a significantly better long-term clinical outcome than
patients undergoing SITA plus SVG. Selected patients un-
dergoing BITA grafting are likely to experience superior
survival, less myocardial infarction and coronary reopera-
tion, and better overall event-free survival. This study adds
to the wealth of clinical data supporting the benefit of BITA
grafting at long-term follow-up. Other studies are needed to
better define the subgroup of patients that most benefits
from BITA grafting.
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Appendix 1
Variables included in the propensity score
● Age: years
● Sex: male/female
● Diabetes: considered present in patients who were receiving
insulin or oral hypoglycemic agents
● Hypertension: defined as a resting blood pressure of 140/90
mm Hg or greater or when patients were receiving antihyper-
tensive medication
● Unstable angina: defined as new or accelerated angina or
angina at rest within 1 month
● Prior myocardial infarction (recent and old): defined as in-
crease of cardiac enzyme levels, presence of a Q wave on
electrocardiography, or both
● Preoperative percutaneous transluminal angioplasty: during
the hospitalization for initial CABG surgery
● Perioperative need for intra-aortic balloon pump: any intra-aortic
balloon pump installed preoperatively, intraoperatively, or post-
operatively during the hospitalization for initial CABG surgery
● Chronic heart failure: defined as a left ventricular ejection frac-
tion of less than 40% not considering diastolic dysfunction
● Peripheral vascular disease: defined as atherosclerotic disease
of any arterial system other than the coronary circulation
documented by means of ultrasonography, angiography, or
direct intraoperative assessment
● Obesity: defined as a body mass index of more than 30 kg/m2
● Dyslipidemia: considered present in patients who were re-
ceiving lipid-lowering drugs
● Chronic obstructive pulmonary disease: considered present in
patients with characteristic findings on roentgenography or on
preoperative diagnostic pulmonary function tests
● Number of coronary artery bypass grafts
APPENDIX 2. Univariate comparison of patients with SITA grafting versus BITA grafting in each quintile identified by the
propensity score
Variable
Quintile 1
(nSITA  249)
(nBITA  612)
P
value
Quintile 2
(nSITA  387),
(nBITA  474)
P
value
Quintile 3
(nSITA  517)
(nBITA  345)
P
value
Quintile 4
(nSITA  614)
(nBITA  247)
P
value
Quintile 5
(nSITA  731)
(nBITA  130)
P
value
Age (y) SITA 50  7 57  7 61  6 65  6 69  6
– – – .02 .001
BITA 50  7 57  6 62  5 66  5 66  6
Sex (male) SITA 96% 94% 87% 76% 48%
– – .07 – .09
BITA 97% 93% 91% 80% 40%
Diabetes SITA 8% 11% 15% 17% 24%
– – – .2 –
BITA 7% 12% 15% 12% 25%
Hypertension SITA 14% 9% 12% 12% 21%
.003 – – – –
BITA 8% 11% 11% 15% 20%
Unstable angina SITA 21% 16% 21% 23% 34%
– – – – –
BITA 20% 20% 19% 25% 28%
Prior MI SITA 29% 26% 29% 29% 39%
– – – .2 –
BITA 24% 25% 30% 32% 43%
Recent MI SITA 6% 5% 9% 8% 13%
– – – – .05
BITA 6% 8% 7% 7% 13%
Preoperative
PCI
SITA 0% 1% 1% 1% 3%
– – – – .05
BITA 0% 1% 1% 1% 3%
IABP needed SITA 5% 3% 7% 9% 11%
– – – – .06
BITA 3% 4% 3% 10% 17%
PVD SITA 4% 6% 6% 7% 12%
.4 – – .2 –
BITA 3% 5% 6% 6% 13%
Dyslipidemia SITA 26% 15% 9% 10% 6%
.1 – – – –
BITA 31% 15% 11% 7% 8%
COPD SITA 4% 3% 4% 4% 12%
– – – – –
BITA 3% 3% 3% 5% 9%
SITA, Single internal thoracic artery; BITA, bilateral internal thoracic artery; MI, myocardial infarction; PCI, percutaneous coronary intervention; IABP,
intra-aortic balloon pump; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease.
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